MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT |
| Katalog-Nr.GC62195 |
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT ist eine Camptothecin-Linker-Verbindung, extrahiert aus dem Patent WO2019195665A1, Beispiel 4-1. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT ist ein Wirkstoff-Linker-Konjugat fÜr AntikÖrper-Wirkstoff-Konjugate (ADC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2378428-19-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker compound extracted from patent WO2019195665A1, example 4-1. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a drug-linker conjugate for antibody-drug conjugate (ADC)[1].
[1]. Jeffrey S, et, al. Camptothecin peptide conjugates. WO2019195665A1.
Average Rating: 5 (Based on Reviews and 19 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *